Artem Lalaiants is the Founder and CEO of RiskSeal with 10+ years in fintech and deep expertise in alternative credit risk scoring. While credit bureaus still anchor lending decisions, customer ...

Researchers report a python metabolite that suppresses appetite in mice, highlighting a potential alternative to current weight-loss drugs. The study, set against widespread use of GLP-1 drugs such as ...

In July of last year, I published an op-ed on asset managers’ growing use of real-time alternative data from various sources to improve decision-making, optimize portfolios, enhance due diligence, and ...

In the spring of 2020, the Federal Reserve faced a challenge: The COVID-19 pandemic was upending daily life with shutdowns, social distancing, and heightened uncertainty, but the traditional economic ...

In this episode of eSpeaks, Jennifer Margles, Director of Product Management at BMC Software, discusses the transition from traditional job scheduling to the era of the autonomous enterprise. eSpeaks’ ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...

As part of the Complement-ARIE consortium, our joint team will advance the understanding of human health and disease by coordinating the full spectrum of data generated across the consortium, ...

New integration lets portfolio managers and research analysts access forward-looking KPI forecasts, dataset-level insights, and predictive analysis through natural language - adding AI-native ...

Maiden Century, a leading alternative data analytics platform for institutional investors, today announced the availability of its new AI workflow integration, making it the first alternative data ...